CSIMarket
 

Heska Corporation  (HSKA)
Other Ticker:  
 

Heska's Working Capital Per Sales

HSKA's Working Capital and Revenue growth



HSKA Working Capital Per Revenue (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Working Capital Change -15.46 % -18.2 % -17.34 % -19.33 % -18.51 %
Y / Y Revenue Change -3.73 % -2.54 % 2.08 % -0.39 % 7.1 %
Working Capital Per Revenue 0.86 0.89 0.93 0.98 1.04
Total Ranking # 2755 # 2634 # 2636 # 1342 # 1690
Seq. Working Capital Change -12.92 % -0.34 % -3.08 % 0.52 % -15.75 %
Seq. Revenue Change -5.96 % 7.88 % -4.92 % -0.19 % -4.8 %





Comment on HSKA's Working Capital Per Revenue in the first quarter 2023
Heska's Working Capital Per Revenue in the Q1 2023 sequentially fell to 0.86 but remained above Heska's average. Due to decrease of revenue year on year in the first quarter 2023 by -3.73%.

Within Healthcare sector 79 other companies have achieved lower Working Capital Per Revenue during the Q1 2023. While Working Capital Per Revenue total ranking has deteriorated in the first quarter 2023, compared to previous quarter from 2634 to 2755.
Working Capital Per Revenue Ranking
Within: No.
Industry # 2
Sector # 80
S&P 500 # 2755


Working Capital Per Revenue Statistics
High Average Low
1.11
0.48
0.19
(Dec 31 2021)   (June 30. 2014)



Financial Statements
Heska's Working Capital $ 196 Millions Visit HSKA's Balance sheet
Heska's Revenues $ 62 Millions Visit HSKA's Income Statement
Where are HSKA's Sales coming from? Visit HSKA's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2023, within Healthcare Sector Working Capital Per Revenue
Cytek Biosciences Inc   2.37 
Veru Inc   2.36 
Cryoport inc   2.30 
Schrodinger Inc   2.30 
Pieris Pharmaceuticals Inc   2.30 
G1 Therapeutics Inc   2.29 
Adaptive Biotechnologies Corporation  2.24 
Clearpoint Neuro Inc   2.19 
2seventy Bio Inc   2.18 
Intra cellular Therapies Inc   2.16 
Sonendo Inc   2.11 
Twist Bioscience Corporation  2.10 
Avita Medical Inc   2.10 
Ocular Therapeutix Inc   2.06 
Assure Holdings Corp   2.04 
Esperion Therapeutics inc   2.04 
Fortress Biotech Inc   2.03 
Mei Pharma Inc   2.02 
Sarepta Therapeutics Inc   2.01 
Repare Therapeutics Inc   2.00 
Pacific Health Care Organization Inc   1.99 
Dariohealth Corp   1.93 
Fibrogen Inc   1.93 
Guardant Health Inc   1.93 
Travere Therapeutics Inc   1.91 
Nanostring Technologies Inc   1.88 
Neuropace Inc   1.87 
Standard Biotools Inc   1.83 
Novocure Limited  1.82 
Pixie Dust Technologies Inc   1.81 
Date modified: 2023-05-06T20:55:06+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com